The gut microbiome, short chain fatty acids, and related metabolites in cystic fibrosis patients with and without colonic adenomas-Reference-Cited by-同舟云学术

The gut microbiome, short chain fatty acids, and related metabolites in cystic fibrosis patients with and without colonic adenomas

Published:2023-07 Issue:4 Volume:22 Page:738-744
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Baldwin-Hunter Brittany L.^ORCID,Rozenberg Felix D.,Annavajhala Medini K.^ORCID,Park Heekuk,DiMango Emily A.,Keating Claire L.,Uhlemann Anne-Catrin^ORCID,Abrams Julian A.^ORCID

Funder

Cystic Fibrosis Foundation

National Center for Advancing Translational Sciences

Abilene Christian University

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference30 articles.

1. Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States;Maisonneuve;J Natl Cancer Inst,2013

2. Cancer risk among lung transplant recipients with cystic fibrosis;Fink;J Cyst Fibros,2016

3. Cystic fibrosis from the gastroenterologist's perspective;Ooi;Nat Rev Gastroenterol Hepatol,2016

4. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis;Manor;Sci Rep,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis;Pediatric Pulmonology;2024-08-06

2. Distinct gut microbiomes in Thai patients with colorectal polyps;World Journal of Gastroenterology;2024-07-21

3. Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis;Journal of Cystic Fibrosis;2024-05

4. Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor;mBio;2024-02-14

5. Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis;2024-02-01